Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00005781 · ClinicalTrials.gov registry record

Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles

A clinical trial of Psoriasis and Dermatitis, sponsored by National Cancer Institute (NCI).

Completed
Registry status
600
Enrollment target
1
Study location

NCT00005781: Completed study of Psoriasis and Dermatitis, sponsored by National Cancer Institute (NCI).

NCT00005781 is a study of Psoriasis and Dermatitis that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 600 participants, above the 484-participant average among 125 other Psoriasis trials with a reported enrollment target (24% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00005781, a study of Psoriasis and Dermatitis, has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
600 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate whether digital photography is a reliable tool for diagnosing hand rashes, psoriasis and unusual moles. The findings will help determine if this method can be used in the National Health and Nutrition Examination survey (NHANES), which monitors disease in the United States. Employees of the National Institutes of Health 19 years and older may enroll in this study. Participants will complete a brief questionnaire that includes information on skin type, history of skin conditions (moles, cancer, rashes, psoriasis), and demographic information such as name, age and sex. They will be examined by a dermatologist, who will note in writing the appearance of any hand rashes, unusual moles, or psoriasis. If any areas suspicious for skin cancer are found, the participant will receive this information in writing, along with advice about where to go for treatment. A total of six photographs will then be taken of the participant's arms, legs, hands and back. The face will not be photographed, and the participants will not be identifiable.

Study Locations (1)

Maryland

  • National Cancer Institute (NCI) - Bethesda

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2000-05
Est. Completion 2000-09
National Cancer Institute (NCI)

3,257 total trials

What the finished NCT00005781 record still lists

NCT00005781 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 484-participant average among 125 other Psoriasis trials with a reported enrollment target (24% higher).

The record links to 3 conditions, with Psoriasis appearing as the primary indexed condition, and to 0 interventions.

NCT00005781 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00005781 about?

NCT00005781 is a clinical study titled "Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles". This study will evaluate whether digital photography is a reliable tool for diagnosing hand rashes, psoriasis and unusual moles. The findings will help determine if this method can be used in the National Health and Nutrition Examination survey (NHANES), which monitors disease in the United States. ...

What is the current status of trial NCT00005781?

This trial is currently completed. The enrollment target is 600 participants. The study started on 2000-05. Estimated completion is 2000-09.

What conditions does trial NCT00005781 study?

This clinical trial studies the following conditions: Psoriasis, Dermatitis, Nevus.

Who is sponsoring clinical trial NCT00005781?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00005781 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Psoriasis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00005781's enrollment target sits among peer trials

600 16th of 125 higher than 110 of 125 other Psoriasis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Psoriasis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

  • NCT01866371 · 600 participants

    High Resolution Retinal Imaging

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00005781, the US trial registry maintained by the National Library of Medicine. NCT00005781 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.